ACE2 and COVID-19: Along with its beneficial cardiovascular effects that may potentially reduce COVID-19 illness severity in patients having cardiovascular complications [102], resveratrol was also shown to directly interfere with the main pathways involved in SARS-CoV-2 pathogenesis including expression of ACE2 and regulation of the renin-angiotensin system [103].